Recent Updates
Recently added Catalysts
ACRS

Aclaris Therapeutics to Attend Upcoming Investor Conferences

Key Takeaway: MALVERN, Pa., May 01, 2017 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage dermatologist-led biotechnology company, today announced that members of its management team will present and host investor meetings at the following upcoming investor events

Conference Participation Details

Jefferies Global Healthcare Conference
Date: November 18, 2025
Time: 11:30 a.m. GMT / 6:30 a.m. ET
Location: London
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

Full Press Release Details

MALVERN, Pa., May 01, 2017 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage dermatologist-led biotechnology company, today announced that members of its management team will present and host investor meetings at the following upcoming investor events:
Management will host investor meetings during the William Blair Late Stage Conference in New York, NY on Wednesday, May 10, 2017.
Management will host investor meetings during the Bank of America Merrill Lynch 2017 Healthcare Conference in Las Vegas, NV on Wednesday and Thursday, May 17 and 18, 2017.
Dr. Neal Walker, President and Chief Executive Officer, will present at Jefferies Global Healthcare Conference in New York, NY on Thursday, June 8, 2017 at 3:30 PM EDT.
Dr. Walker will also present at William Blair Growth Stock Conference in Chicago, IL, on Tuesday, June 13, 2017 at 7:30 AM CDT.
Management will host investor meetings during the JMP Securities Life Sciences Conference in New York, NY on Tuesday, June 20, 2017.
A live webcast of the Jefferies Global Healthcare Conference and the William Blair Growth Stock Conference presentations may be accessed through the Company's web site, www.aclaristx.com, on the 'Events and Presentations' section. An archived version of the presentation will be available for 30 days.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage dermatologist-led biotechnology company focused on identifying, developing and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology. Aclaris is based in Malvern, Pennsylvania and more information can be found by visiting the Aclaris website at www.aclaristx.com.

Contact Data

Vice President / Investor Relations

Contact

With a Reader Account, it's easy to send email directly to the contact for this release. Sign up today for your free Reader Account!
Already have an account? Log in here.
Last updated: May 1, 2017